Advertisement

Superficial Chemical Peels and Microdermabrasion

  • Rachel Miest
Chapter

Abstract

Superficial skin resurfacing is a process causing controlled injury to the epidermis. Processes can be chemical or mechanical and classified as laser or nonlaser. Although our armamentarium for skin resurfacing ranges from topical medicaments to ablative lasers, superficial skin resurfacing with chemical peels and microdermabrasion (MDA) has maintained its popularity. These well-established therapies have proven safe and effective, offer minimal risk, low cost, and are well-tolerated by patients often with little to no post-procedure downtime. Potential benefits extend to all Fitzpatrick skin types and if done appropriately are highly unlikely to cause significant dyspigmentation or scarring. Indications for treatment are acne vulgaris, rosacea, post-inflammatory hyperpigmentation, melasma, and photodamage including lentigines, fine rhytides, and actinic keratoses. Superficial resurfacing with chemical peels or MDA can be used in combination with other therapies (e.g., laser) and may enhance the efficacy of other topical treatments. A superficial depth of penetration may be of significant benefit to the patient but does have limitations. It is important for patients to understand the likely need for a series of treatments, the importance of pre- and post-care regimens, and expected outcomes.

Keywords

Chemical peels Alpha hydroxy acid peels Salicylic acid peels Jessner’s solution (JS) Microdermabrasion 

References

  1. 1.
    Dréno B, Fischer TC, Perosino E, Poli F, Viera MS, Rendon MI, et al. Expert opinion: efficacy of superficial chemical peels in active acne management–what can we learn from the literature today? Evidence-based recommendations. J Eur Acad Dermatol Venereol. 2011 Jun;25(6):695–704.CrossRefPubMedGoogle Scholar
  2. 2.
    Bolognia JL, Jorizzo JJ, Schaffer JV, Callen JP, Cerroni L, Heymann WR, et al. Dermatology. 3rd ed. London: Elsevier; 2012.Google Scholar
  3. 3.
    Roenigk RK, Broadland DG. A primer of facial chemical peel. Dermatol Clin. 1993;11(2):349–59.CrossRefPubMedGoogle Scholar
  4. 4.
    Rendon MI, Berson DS, Cohen JL, Roberts WE, Starker I, Wang B. Evidence and considerations in the application of chemical peels in skin disorders and aesthetic resurfacing. J Clin Aesthet Dermatol. 2010;3(7):32–43.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Coleman WP, Brody HJ. Advances in chemical peeling. Dermatol Clin. 1997 Jan;15(1):19–26.CrossRefPubMedGoogle Scholar
  6. 6.
    Fischer TC, Perosino E, Poli F, Viera MS, Dréno B. Chemical peels in aesthetic dermatology: an update 2009. J Eur Acad Dermatol Venereol. 2010;24(3):281–92. Blackwell Publishing Ltd.CrossRefPubMedGoogle Scholar
  7. 7.
    Berson DS, Cohen JL, Rendon MI, Roberts WE, Starker I, Wang B. Clinical role and application of superficial chemical peels in today’s practice. J Drugs Dermatol. 2009 Sep;8(9):803–11.PubMedGoogle Scholar
  8. 8.
    Sharad J. Glycolic acid peel therapy – a current review. Clin Cosmet Investig Dermatol. 2013;6:281–8.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Garg VK, Sarkar R, Agarwal R. Comparative evaluation of beneficiary effects of priming agents (2% hydroquinone and 0.025% retinoic acid) in the treatment of melasma with glycolic acid peels. Dermatol Surg. 2008;34(8):1032–9; discussion 1340.PubMedGoogle Scholar
  10. 10.
    Monheit GD, Chastain MA. Chemical peels. Facial Plast Surg Clin North Am. 2001;9(2):239–55; viii.PubMedGoogle Scholar
  11. 11.
    Landau M. Chemical peels. Clin Dermatol. 2008;26:200–8.CrossRefPubMedGoogle Scholar
  12. 12.
    Resnik SS, Resnik BI. Complications of chemical peeling. Dermatol Clin. 1995;13(2):309–12.CrossRefPubMedGoogle Scholar
  13. 13.
    Murad H, Shamban AT, Premo PS. The use of glycolic acid as a peeling agent. Dermatol Clin. 1995;13(2):285–307.CrossRefPubMedGoogle Scholar
  14. 14.
    Van Scott EJ, Ditre CM, Yu RJ. Alpha-hydroxyacids in the treatment of signs of photoaging. Clin Dermatol. 1996;14(2):217–26.CrossRefPubMedGoogle Scholar
  15. 15.
    Ditre CM. Glycolic acid peels. Dermatol Ther. 2000;13(2):165–72. Blackwell Science Inc.CrossRefGoogle Scholar
  16. 16.
    Van Scott EJ, Yu RJ. Hyperkeratinization, corneocyte cohesion, and alpha hydroxy acids. J Am Acad Dermatol. 1984;11(5):867–79. Mosby.CrossRefPubMedGoogle Scholar
  17. 17.
    Kim SJ, Park JH, Kim DH, Won YH, Maibach HI. Increased in vivo collagen synthesis and in vitro cell proliferative effect of glycolic acid. Dermatol Surg. 1998 Oct;24(10):1054–8.CrossRefPubMedGoogle Scholar
  18. 18.
    Erbil H, Sezer E, Tastan B, Arca E, Kurumlu Z. Efficacy and safety of serial glycolic acid peels and a topical regimen in the treatment of recalcitrant melasma. J Dermatol. 2007;34(1):25–30. Blackwell Publishing Asia.CrossRefPubMedGoogle Scholar
  19. 19.
    Yamamoto Y, Uede K, Yonei N, Kishioka A, Ohtani T, Furukawa F. Effects of alpha-hydroxy acids on the human skin of Japanese subjects: the rationale for chemical peeling. J Dermatol. 2006;33(1):16–22. Blackwell Publishing Asia.CrossRefPubMedGoogle Scholar
  20. 20.
    Moy LS, Peace S, Moy RL. Comparison of the effect of various chemical peeling agents in a mini-pig model. Dermatol Surg. 1996;22(5):429–32. Blackwell Publishing Ltd.CrossRefPubMedGoogle Scholar
  21. 21.
    Usuki A, Ohashi A, Sato H, Ochiai Y, Ichihashi M, Funasaka Y. The inhibitory effect of glycolic acid and lactic acid on melanin synthesis in melanoma cells. Exp Dermatol. 2003;12(Suppl 2):43–50.CrossRefPubMedGoogle Scholar
  22. 22.
    Takenaka Y, Hayashi N, Takeda M, Ashikaga S, Kawashima M. Glycolic acid chemical peeling improves inflammatory acne eruptions through its inhibitory and bactericidal effects on Propionibacterium acnes. J Dermatol. 2012 Apr;39(4):350–4.CrossRefPubMedGoogle Scholar
  23. 23.
    Deprez P. Textbook of chemical peels. Superficial, medium, and deep peels in cosmetic practice. London: Informa UK; 2007.CrossRefGoogle Scholar
  24. 24.
    Van Scott EJ. Control of keratinization with a-hydroxy acids and related compounds. Arch Dermatol. 1974;110(4):586–90. American Medical Association.CrossRefPubMedGoogle Scholar
  25. 25.
    Ditre CM, Griffin TD, Murphy GF, Sueki H, Telegan B, Johnson WC, et al. Effects of α-hydroxy acids on photoaged skin: a pilot clinical, histologic, and ultrastructural study. J Am Dermatol. 1996;34(2):187–95. Mosby.CrossRefGoogle Scholar
  26. 26.
    Butler PE, González S, Randolph MA, Kim J, Kollias N, Yaremchuk MJ. Quantitative and qualitative effects of chemical peeling on photo-aged skin: an experimental study. Plast Reconstr Surg. 2001 Jan;107(1):222–8.CrossRefPubMedGoogle Scholar
  27. 27.
    Newman N, Newman A, Moy LS, Babapour R, Harris AG, Moy RL. Clinical improvement of photoaged skin with 50% glycolic acid. A double-blind vehicle-controlled study. Dermatol Surg. 1996 May;22(5):455–60.CrossRefPubMedGoogle Scholar
  28. 28.
    Alam M, Omura NE, Dover JS, Arndt KA. Glycolic acid peels compared to microdermabrasion: a right-left controlled trial of efficacy and patient satisfaction. Dermatol Surg. 2002 Jun;28(6):475–9.PubMedGoogle Scholar
  29. 29.
    Lim JT, Tham SN. Glycolic acid peels in the treatment of melasma among Asian women. Dermatol Surg. 1997;23(3):177–9.CrossRefPubMedGoogle Scholar
  30. 30.
    Lawrence N, Cox SE, Brody HJ. Treatment of melasma with Jessner’s solution versus glycolic acid: a comparison of clinical efficacy and evaluation of the predictive ability of Wood’s light examination. J Am Acad Dermatol. 1997 Apr;36(4):589–93.CrossRefPubMedGoogle Scholar
  31. 31.
    Sarkar R, Kaur C, Bhalla M, Kanwar AJ. The combination of glycolic acid peels with a topical regimen in the treatment of melasma in dark-skinned patients: a comparative study. Dermatol Surg. 2002;28(9):828–32. Blackwell Science Inc.PubMedGoogle Scholar
  32. 32.
    Hurley ME, Guevara IL, Gonzales RM, Pandya AG. Efficacy of glycolic acid peels in the treatment of melasma. Arch Dermatol. 2002;138(12):1578–82. American Medical Association.CrossRefPubMedGoogle Scholar
  33. 33.
    Coleman WP 3rd, Brody HJ. Efficacy of low-strength glycolic acid application in the treatment of melasma. Arch Dermatol. 2003;139(6):811; author reply 811–2.CrossRefPubMedGoogle Scholar
  34. 34.
    Sharquie KE, Al-Tikreety MM, Al-Mashhadani SA. Lactic acid as a new therapeutic peeling agent in melasma. Dermatol Surg. 2005;31(2):149–54; discussion 154.CrossRefPubMedGoogle Scholar
  35. 35.
    Sharquie KE, Tikreety MM, Al-Mashhadani SA. Lactic acid chemical peels as a new therapeutic modality in melasma in comparison to Jessner’s solution chemical peels. Dermatologic Surgery. 2006;32(12):1429–36.PubMedGoogle Scholar
  36. 36.
    Sarkar R, Garg V, Bansal S, Sethi S, Gupta C. Comparative evaluation of efficacy and tolerability of glycolic acid, salicylic mandelic acid, and phytic acid combination peels in melasma. Dermatol Surg. 2016;42(3):384–91.CrossRefPubMedGoogle Scholar
  37. 37.
    Wang CM, Li HC, Sindy Hu CT, Chan HL. The effect of glycolic acid on the treatment of acne in Asian skin. Dermatol Surg Blackwell Publishing Ltd. 1997;23(1):23–9.CrossRefPubMedGoogle Scholar
  38. 38.
    Atzori L, Brundu MA, Orru A, Biggio P. Glycolic acid peeling in the treatment of acne. J Eur Acad Dermatol Venereol. 1999;12(2):119–22. Blackwell Publishing Ltd.CrossRefPubMedGoogle Scholar
  39. 39.
    Kim SW, Moon SE, Kim JA, Eun HC. Glycolic acid versus Jessner’s solution: which is better for facial acne patients? Dermatol Surg. 1999;25(4):270–3. Blackwell Science Inc.CrossRefPubMedGoogle Scholar
  40. 40.
    Kessler E, Flanagan K, Chia C, Rogers C, Glaser DA. Comparison of alpha- and beta-hydroxy acid chemical peels in the treatment of mild to moderately severe facial acne vulgaris. Dermatol Surg. 2008;34(1):45–50; discussion 51.CrossRefPubMedGoogle Scholar
  41. 41.
    Lee SH, Huh CH, Park KC, Youn SW. Effects of repetitive superficial chemical peels on facial sebum secretion in acne patients. J Eur Acad Dermatol Venereol. 2006 Sep;20(8):964–8.PubMedGoogle Scholar
  42. 42.
    Kaminaka C, Uede M, Matsunaka H, Furukawa F, Yamomoto Y. Clinical evaluation of glycolic acid chemical peeling in patients with acne vulgaris: a randomized, double-blind, placebo-controlled, split-face comparative study. Dermatol Surg. 2014;40(3):314–22.CrossRefPubMedGoogle Scholar
  43. 43.
    Burns RL, Prevost-Blank PL, Lawry MA, Lawry TB, Faria DT, Fivenson DP. Glycolic acid peels for postinflammatory hyperpigmentation in black patients. A comparative study. Dermatol Surg. 1997;23(3):171–4; discussion 175.CrossRefPubMedGoogle Scholar
  44. 44.
    Garg VK, Sinha S, Sarkar R. Glycolic acid peels versus salicylic-mandelic acid peels in active acne vulgaris and post-acne scarring and hyperpigmentation: a comparative study. Dermatol Surg. 2009 Jan;35(1):59–65.PubMedGoogle Scholar
  45. 45.
    Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial‐ethnic groups. Dermatol Surg. 1999;25(1):18–22.CrossRefPubMedGoogle Scholar
  46. 46.
    Kodali S, Guevara IL, Carrigan CR, Daulat S, Blanco G, Boker A, et al. A prospective, randomized, split-face, controlled trial of salicylic acid peels in the treatment of melasma in Latin American women. J Am Acad Dermatol. 2010 Dec;63(6):1030–5.CrossRefPubMedGoogle Scholar
  47. 47.
    Ejaz A, Raza N, Iftikhar N, Muzzafar F. Comparison of 30% salicylic acid with Jessner’s solution for superficial chemical peeling in epidermal melasma. J Coll Physicians Surg Pak. 2008;18(4):205–8.PubMedGoogle Scholar
  48. 48.
    Joshi SS, Boone SL, Alam M, Yoo S, White L, Rademaker A, et al. Effectiveness, safety, and effect on quality of life of topical salicylic acid peels for treatment of postinflammatory hyperpigmentation in dark skin. Dermatol Surg. 2009;35(4):638–44; discussion 644.CrossRefPubMedGoogle Scholar
  49. 49.
    Kligman D, Kligman A. Salicylic acid peels for the treatment of photoaging. Dermatol Surg. 1998;24(3):325–8. Blackwell Publishing Ltd.CrossRefPubMedGoogle Scholar
  50. 50.
    Dainichi T, Ueda S, Isoda M, Koga T, Kinukawa N, Nose Y, et al. Chemical peeling with salicylic acid in polyethylene glycol vehicle suppresses skin tumour development in hairless mice. Br J Dermatol. 2003 May;148(5):906–12.CrossRefPubMedGoogle Scholar
  51. 51.
    Yu RJ, Van Scott EJ. Salicylic acid: not a b-hydroxy acid. Cosmet Dermatol. 1997.Google Scholar
  52. 52.
    Arif T. Salicylic acid as a peeling agent: a comprehensive review. Clin Cosmet Investig Dermatol. 2015;8:455. Dove Press.CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Imayama S, Ueda S, Isoda M. Histologic changes in the skin of hairless mice following peeling with salicylic acid. Arch Dermatol. 2000 Nov;136(11):1390–5.CrossRefPubMedGoogle Scholar
  54. 54.
    Rawlings A, Harding C, Watkinson A, Banks J, Ackerman C, Sabin R. The effect of glycerol and humidity on desmosome degradation in stratum corneum. Arch Dermatol Res. 1995;287(5):457–64.CrossRefPubMedGoogle Scholar
  55. 55.
    Lazo ND, Meine JG, Downing DT. Lipids are covalently attached to rigid corneocyte protein envelopes existing predominantly as β-sheets: a solid-state nuclear magnetic resonance study. J Investig Dermatol. 1995;105(2):296–300. Elsevier.CrossRefPubMedGoogle Scholar
  56. 56.
    Akhavan A, Bershad S. Topical acne drugs: review of clinical properties, systemic exposure, and safety. Am J Clin Dermatol. 2003;4(7):473–92.CrossRefPubMedGoogle Scholar
  57. 57.
    Starling J III, Karimipour DJ. Nonlaser superficial resurfacing techniques: superficial chemical peels and microdermabrasion. New York: Springer; 2012. p. 301–16.Google Scholar
  58. 58.
    Ueda S, Mitsugi K, Ichige K, Yoshida K, Sakuma T, Ninomiya S-I, et al. New formulation of chemical peeling agent: 30% salicylic acid in polyethylene glycol. Absorption and distribution of 14C-salicylic acid in polyethylene glycol applied topically to skin of hairless mice. J Dermatol Sci. 2002 Apr;28(3):211–8.CrossRefPubMedGoogle Scholar
  59. 59.
    Lévêque JL, Corcuff P, Rougier A, Piérard GE. Mechanism of action of a lipophilic salicylic acid derivative on normal skin. Eur J Dermatol. 2002 Jul;12(4):XXXV–XXXVIII.PubMedGoogle Scholar
  60. 60.
    Uhoda E, Piérard-Franchimont C, Piérard GE. Comedolysis by a lipohydroxyacid formulation in acne-prone subjects. Eur J Dermatol. 2003 Jan;13(1):65–8.PubMedGoogle Scholar
  61. 61.
    Lee HS, Kim IH. Salicylic acid peels for the treatment of acne vulgaris in Asian patients. Dermatol Surg. 2003;29(12):1196–9.PubMedGoogle Scholar
  62. 62.
    Ahn HH, Kim IH. Whitening effect of salicylic acid peels in Asian patients. Dermatol Surg. 2006;32(3):372–5. Blackwell Publishing Inc.PubMedGoogle Scholar
  63. 63.
    Dainichi T, Ueda S, Imayama S, Furue M. Excellent clinical results with a new preparation for chemical peeling in acne: 30% salicylic acid in polyethylene glycol vehicle. Dermatol Surg. 2008;34(7):891–9; discussion 899.PubMedGoogle Scholar
  64. 64.
    Hashimoto Y, Suga Y, Mizuno Y, Hasegawa T, Matsuba S, Ikeda S, et al. Salicylic acid peels in polyethylene glycol vehicle for the treatment of comedogenic acne in Japanese patients. Dermatol Surg. 2008;34(2):276–9; discussion 279.CrossRefPubMedGoogle Scholar
  65. 65.
    Bae BG, Park CO, Shin H, Lee SH, Lee YS, Lee SJ, et al. Salicylic acid peels versus Jessner’s solution for acne vulgaris: a comparative study. Dermatol Surg. 2013 Feb;39(2):248–53.CrossRefPubMedGoogle Scholar
  66. 66.
    Dayal S, Amrani A, Sahu P, Jain VK. Jessner’s solution vs. 30% salicylic acid peels: a comparative study of the efficacy and safety in mild‐to‐moderate acne vulgaris. J Cosmet Dermatol. 2017;16(1):43–51.CrossRefPubMedGoogle Scholar
  67. 67.
    Monheit GD. The Jessner’s+ TCA peel: a medium-depth chemical peel. J Dermatol Surg Oncol. 1989;15(9):945–50.CrossRefPubMedGoogle Scholar
  68. 68.
    Monheit GD. Chemical peels. Skin Therapy Lett. 2004;9(2):6–11.Google Scholar
  69. 69.
    Monteleone, G. Microdermabrasion with aluminum hydroxide powder in scars camouflaging. In Proceedings of the 3rd meeting of Southern Italy Plastic Surgery Association, Benevento; 1988. pp. 9–10.Google Scholar
  70. 70.
    Guidance for Industry – Guidance for Dermabrasion Devices [Internet]. [cited 2016 Dec 15]. Available from: http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm073788.htm
  71. 71.
    Kirkland EB, Hantash BM. Microdermabrasion: molecular mechanisms unraveled, part 2. J Drugs Dermatol. 2012 Sep;11(9):e10–7.PubMedGoogle Scholar
  72. 72.
    Reddy BY, Hantash BM. Emerging technologies in aesthetic medicine. Dermatol Clin. 2009;27(4):521–7; vii–viii.CrossRefPubMedGoogle Scholar
  73. 73.
    Shim EK, Barnette D, Hughes K, Greenway HT. Microdermabrasion: a clinical and histopathologic study. Dermatol Surg. 2001;27(6):524–30. Blackwell Science, Inc.PubMedGoogle Scholar
  74. 74.
    Tsai RY, Wang CN, Chan HL. Aluminum oxide crystal microdermabrasion. Dermatol Surg. 1995;21(6):539–42. Blackwell Publishing Ltd.CrossRefPubMedGoogle Scholar
  75. 75.
    Tan MH, Spencer JM, Pires LM, Ajmeri J, Skover G. The evaluation of aluminum oxide crystal microdermabrasion for photodamage. Dermatol Surg. 2001;27(11):943–9. Blackwell Science, Inc.PubMedGoogle Scholar
  76. 76.
    Lloyd JR. The use of microdermabrasion for acne: a pilot study. Dermatol Surg. 2001;27(4):329–31. Blackwell Science, Inc.PubMedGoogle Scholar
  77. 77.
    Hernandez Perez E, Ibiett EV. Gross and microscopic findings in patients undergoing microdermabrasion for facial rejuvenation. Dermatol Surg. 2001;27(7):637–40. Blackwell Science, Inc.PubMedGoogle Scholar
  78. 78.
    Coimbra M, Rohrich RJ, Chao J, Brown SA. A prospective controlled assessment of microdermabrasion for damaged skin and fine Rhytides. Plast Reconstr Surg. 2004;113(5):1438.CrossRefPubMedGoogle Scholar
  79. 79.
    Bhalla M, Thami GP. Microdermabrasion: reappraisal and brief review of literature. Dermatol Surg. 2006;32(6):809–14.PubMedGoogle Scholar
  80. 80.
    El-Domyati M, Hosam W, Abdel Azim E, Abdel Wahab H, Mohamed E. Microdermabrasion: a clinical, histometric, and histopathologic study. J Cosmet Dermatol. 2016;15(4):503–13.CrossRefPubMedGoogle Scholar
  81. 81.
    Abdel-Latif AM, Elbendary AS. Treatment of striae distensae with microdermabrasion: a clinical and molecular study. JEWDS. 2008;5:24–30.Google Scholar
  82. 82.
    Freedman BM, Rueda Pedraza E, Waddell SP. The epidermal and dermal changes associated with microdermabrasion. Dermatol Surg. 2001;27(12):1031–4. Blackwell science, Inc.PubMedGoogle Scholar
  83. 83.
    Hussein MRA, Ab-Deif EE, Abdel-Motaleb AA, Zedan H, Abdel-Meguid AM. Chemical peeling and microdermabrasion of the skin: comparative immunohistological and ultrastructural studies. J Dermatol Sci. 2008 Dec;52(3):205–9.CrossRefPubMedGoogle Scholar
  84. 84.
    Karimipour DJ, Kang S, Johnson TM, Orringer JS, Hamilton T, Hammerberg C, et al. Microdermabrasion: a molecular analysis following a single treatment. J Am Acad Dermatol. 2005 Feb;52(2):215–23.CrossRefPubMedGoogle Scholar
  85. 85.
    Karimipour DJ, Kang S, Johnson TM, Orringer JS, Hamilton T, Hammerberg C, et al. Microdermabrasion with and without aluminum oxide crystal abrasion: a comparative molecular analysis of dermal remodeling. J Am Acad Dermatol. 2006;54(3):405–10.CrossRefPubMedGoogle Scholar
  86. 86.
    Rajan P, Grimes PE. Skin barrier changes induced by aluminum oxide and sodium chloride microdermabrasion. Dermatol Surg. 2002;28(5):390–3.PubMedGoogle Scholar
  87. 87.
    Andrews SN, Zarnitsyn V, Bondy B, Prausnitz MR. Optimization of microdermabrasion for controlled removal of stratum corneum. Int J Pharm. 2011;407(1–2):95–104.CrossRefPubMedPubMedCentralGoogle Scholar
  88. 88.
    Lee WR, Tsai RY, Fang CL, Liu CJ, Hu CH, Fang JY. Microdermabrasion as a novel tool to enhance drug delivery via the skin: an animal study. Dermatol Surg. 2006;32(8):1013–22.PubMedGoogle Scholar
  89. 89.
    Karimipour DJ, Karimipour G, Orringer JS. Microdermabrasion: an evidence-based review. Plast Reconstr Surg. 2010;125(1):372–7.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Rachel Miest
    • 1
  1. 1.Department of DermatologyMayo ClinicRochesterUSA

Personalised recommendations